We invest considerable sums of money in the development of novel products. Our principal domain are generic drugs thanks to which we can provide a wide range of patients with access to modern therapies. We conduct our own research and development activities and collaborate with universities and research institutes in Poland and abroad. In Starogard Gdański, we have created one of the largest development centres in Central and Eastern Europe with state-of-the-art analytical equipment and machines for production on laboratory and semi-technical scales. The Polpharma Group and associated company Akrikhin has a total of 7 development centres employing over 400 high-class specialists who deliver between 30 and 40 new solutions each year.
The Research and Development Centre
- Has at its disposal state-of-the-art laboratory and manufacturing equipment and machines for production on laboratory and semi-technical scales.
- Employs high-class pharmacy and chemistry specialists.
- Collaborates with numerous scientific facilities in Poland and foreign experts.
The projects associated with the development of new products are focused on the following categories:
- cardiovascular drugs,
- gastrointestinal drugs,
- neurological drugs,
- OTC products.